News | Lung Imaging | April 23, 2018

National Cancer Institute Grant Creates National Lung Cancer Screening Center

Joint effort of five health systems will work to improve lung cancer screening and reduce disparities nationwide

National Cancer Institute Grant Creates National Lung Cancer Screening Center

April 23, 2018 — Researchers from the Perelman School of Medicine at the University of Pennsylvania and four other institutions have received a five-year, $15.5 million National Cancer Institute (NCI) grant to improve lung cancer screening. Specifically, the focus will be on improving the effectiveness of screening, and increasing the delivery of screening in populations that experience disparities in early diagnosis, treatment and mortality.

The other grant-receiving institutions include:

  • The Institute for Health Research at Kaiser Permanente Colorado;
  • Kaiser Permanente Hawaii;
  • The Henry Ford Health System in Detroit; and
  • Marshfield Clinic Health System in Wisconsin.

The funding will establish the Center for Research to Optimize Precision Lung Cancer Screening (CPLS), one of three specialized cancer screening research centers under the Population-based Research to Optimize the Screening Process II (PROSPR II) initiative by the Healthcare Delivery Research Program at NCI. The center will develop a shared model data for a lung cancer screening data repository to conduct research on developing and testing ways to prevent underuse, overuse, and misuse of screening for lung cancer nationally.

The new center — co-directed by Chyke Doubeni, M.D., chair of family medicine and community health at the Perelman School of Medicine, and Debra P. Ritzwoller, Ph.D., of Kaiser Permanente — joins scientists from five health systems contributing to the NCI-funded Population-Based Research to Optimize the Screening Process II (PROSPR II) Initiative for lung, colon, and cervical cancer. PROSPR II promotes research focused on evaluating and improving cancer screening.

“Lung cancer disparities present an urgent public health crisis in most communities across the United States,” said Doubeni. “We’ve seen some hope in low-dose computed tomography [CT] screening to reduce the risk of lung cancer and also as an opportunity to promote smoking cessation treatments, but many questions remain about the best way to optimize the delivery of screening in our communities. I look forward to the collaborative work by these diverse institutions to tackle these issues in depth and develop best practices for improving the delivery and effectiveness of screening.”

Lung cancer is the highest cause of cancer deaths in the United States, according to the National Cancer Institute, taking the lives of an estimated 154,050 people annually. When performed in a timely manner, screening can find lung cancer at more treatable stages.

In addition to Doubeni, the interdisciplinary research team at Penn includes Mitchell Schnall, Anil Vachani, Despina Kontos, Katherine Rendle, Jason Roy, Fran Barg and Michael Horst.

For more information: www.med.upenn.edu

 

Related Content

Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...
The use of CT and X-ray in the assessment and treatment plan for President Trump underscores the critical role that medical imaging must play in the fight against COVID-19

A COVID-19 chest CT heat map from RADlogics

News | Artificial Intelligence | October 13, 2020
October 13, 2020 — Given recent high-profile cases of...
A, Sagittal reformatted bone window CT image of thoracic spine shows wedge-shaped deformity at T6 and subtle superior endplate deformities at T5 and T8. Arrows denote deformities. B, Color-coded dual-energy CT shows only T8 deformity is associated with bone marrow edema; T5 and T6 deformities likely represent chronic fractures. Arrows denote deformities.

A, Sagittal reformatted bone window CT image of thoracic spine shows wedge-shaped deformity at T6 and subtle superior endplate deformities at T5 and T8. Arrows denote deformities. B, Color-coded dual-energy CT shows only T8 deformity is associated with bone marrow edema; T5 and T6 deformities likely represent chronic fractures. Arrows denote deformities.

News | Computed Tomography (CT) | October 06, 2020